Products
Vectura has an innovative and broad clinical pipeline that combines mid- and late-stage programmes with earlier-stage opportunities, addressing large and fast-growing market sectors, as well as a portfolio of revenue generating, marketed products.
Vectura has proprietary inhalation device and formulation technologies, which it uses to develop products in-house and with its pharmaceutical company partners.
Please use this page to learn more about the inhaled pharmaceuticals that Vectura is developing and its proprietary technologies.
Intellectual property
Information about Vectura’s patents and how it obtains additional value from its IP.More
